FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043934883> ?p ?o ?g. }

• W2043934883 endingPage "225" @default.
• W2043934883 startingPage "211" @default.
• W2043934883 abstract "Although 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a known serotonergic neurotoxin in different animal species, there is to date no conclusive evidence of its neurotoxicity in humans. MDMA use was associated with impairments of psychological well-being, verbal memory and altered serotonergic functioning in a number of crosssectional studies. Due to inherent methodological limitations, such as the notorious polydrug use of ecstasy users and lack of control of possible pre-existing differences between ecstasy users and control participants, researchers have called for well-controlled, prospective longitudinal studies to shed more light on the issue of MDMA neurotoxicity to the human brain. This longitudinal study investigated whether mood, cognition and central serotonin transporters (SERT) would deteriorate with continued MDMA use and whether or not they would recover over increasing periods of MDMA abstinence. In a repeated-measures design, 11 current and ten ex-ecstasy users, and 11 polydrug (but not MDMA) and 15 drug-naive controls participated three times within approximately two years. Both ecstasy user groups reported a polydrug use pattern besides heavy ecstasy use. Subjective reports of ecstasy use or abstinence were veri.ed by toxicological analyses. On each trial, the participants underwent a cognitive test battery and .lled in the Symptom Check List. The availability of central SERT was assessed with positron emission tomography using the McN5652 ligand for all groups at t1, and only for the ecstasy user groups on follow-ups. The factor Group yielded signi.cant results in the SCL-90 scales Global Severity Index, Anxiety, Obsessive/compulsive and Interpersonal sensitivity, with the ex-ecstasy users reporting the highest symptom scores. There were signi.cant Group effects in all measures of verbal memory, with the lowest performance in the group of ex-ecstasy users. The repeated-measures analyses yielded no signi.cant Group × Time interactions in any SCL-90 scales or measures of memory performance, with the exception of AVLT 1 immediate recall. Thus the ex-ecstasy users' psychopathological symptoms and memory performance failed to improve, and the current ecstasy users' failed to deteriorate, over time relative to the other groups. While there was a signi.cant effect of Group in all brain regions examined (except the control region white matter), the current users' SERT availability seems to have recovered in the mesencephalon, as indicated by a signi.cant Group × Time interaction. Reduced SERT availability might be a transient effect of heavy ecstasy use, since it partially recovered as the current users reduced their MDMA use. However, this measure may not necessarily be a valid indicator of the number or integrity of serotonergic neurons. Ex-ecstasy users' verbal memory showed no sign of improvement even after over 2.5 years of abstinence and thus may represent persistent functional consequences of MDMA neurotoxicity. However, alternative causes such as pre-existing group differences cannot be completely ruled out in spite of the longitudinal design." @default.
• W2043934883 created "2016-06-24" @default.
• W2043934883 creator A5013302415 @default.
• W2043934883 creator A5015194593 @default.
• W2043934883 creator A5033112119 @default.
• W2043934883 creator A5034653432 @default.
• W2043934883 creator A5043073398 @default.
• W2043934883 creator A5072841040 @default.
• W2043934883 creator A5078470376 @default.
• W2043934883 creator A5084177711 @default.
• W2043934883 date "2006-03-01" @default.
• W2043934883 modified "2023-10-17" @default.
• W2043934883 title "Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective" @default.
• W2043934883 cites W1580711543 @default.
• W2043934883 cites W1693348571 @default.
• W2043934883 cites W1965630869 @default.
• W2043934883 cites W1980443637 @default.
• W2043934883 cites W1982483542 @default.
• W2043934883 cites W1987444921 @default.
• W2043934883 cites W1988137292 @default.
• W2043934883 cites W1991339455 @default.
• W2043934883 cites W1999770647 @default.
• W2043934883 cites W2010443735 @default.
• W2043934883 cites W2016762802 @default.
• W2043934883 cites W2019894480 @default.
• W2043934883 cites W2024256764 @default.
• W2043934883 cites W2029725188 @default.
• W2043934883 cites W2036111662 @default.
• W2043934883 cites W2042631922 @default.
• W2043934883 cites W2047944520 @default.
• W2043934883 cites W2052646227 @default.
• W2043934883 cites W2064064600 @default.
• W2043934883 cites W2065603322 @default.
• W2043934883 cites W2072556144 @default.
• W2043934883 cites W2088299224 @default.
• W2043934883 cites W2093527826 @default.
• W2043934883 cites W2096542780 @default.
• W2043934883 cites W2098659673 @default.
• W2043934883 cites W2108989220 @default.
• W2043934883 cites W2109058455 @default.
• W2043934883 cites W2109698385 @default.
• W2043934883 cites W2115752255 @default.
• W2043934883 cites W2116488270 @default.
• W2043934883 cites W2118707538 @default.
• W2043934883 cites W2127538073 @default.
• W2043934883 cites W2132011757 @default.
• W2043934883 cites W2132159513 @default.
• W2043934883 cites W2137899752 @default.
• W2043934883 cites W2139273914 @default.
• W2043934883 cites W2143162373 @default.
• W2043934883 cites W2154998383 @default.
• W2043934883 cites W2155111399 @default.
• W2043934883 cites W2155890773 @default.
• W2043934883 cites W2167091782 @default.
• W2043934883 cites W2167729602 @default.
• W2043934883 cites W2171120634 @default.
• W2043934883 cites W2171847604 @default.
• W2043934883 cites W2334301455 @default.
• W2043934883 cites W4300889188 @default.
• W2043934883 doi "https://doi.org/10.1177/0269881106059486" @default.
• W2043934883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16510479" @default.
• W2043934883 hasPublicationYear "2006" @default.
• W2043934883 type Work @default.
• W2043934883 sameAs 2043934883 @default.
• W2043934883 citedByCount "135" @default.
• W2043934883 countsByYear W20439348832012 @default.
• W2043934883 countsByYear W20439348832013 @default.
• W2043934883 countsByYear W20439348832014 @default.
• W2043934883 countsByYear W20439348832015 @default.
• W2043934883 countsByYear W20439348832016 @default.
• W2043934883 countsByYear W20439348832017 @default.
• W2043934883 countsByYear W20439348832018 @default.
• W2043934883 countsByYear W20439348832020 @default.
• W2043934883 countsByYear W20439348832021 @default.
• W2043934883 countsByYear W20439348832022 @default.
• W2043934883 countsByYear W20439348832023 @default.
• W2043934883 crossrefType "journal-article" @default.
• W2043934883 hasAuthorship W2043934883A5013302415 @default.
• W2043934883 hasAuthorship W2043934883A5015194593 @default.
• W2043934883 hasAuthorship W2043934883A5033112119 @default.
• W2043934883 hasAuthorship W2043934883A5034653432 @default.
• W2043934883 hasAuthorship W2043934883A5043073398 @default.
• W2043934883 hasAuthorship W2043934883A5072841040 @default.
• W2043934883 hasAuthorship W2043934883A5078470376 @default.
• W2043934883 hasAuthorship W2043934883A5084177711 @default.
• W2043934883 hasConcept C118552586 @default.
• W2043934883 hasConcept C126322002 @default.
• W2043934883 hasConcept C15744967 @default.
• W2043934883 hasConcept C169900460 @default.
• W2043934883 hasConcept C170493617 @default.
• W2043934883 hasConcept C2775864247 @default.
• W2043934883 hasConcept C2778897192 @default.
• W2043934883 hasConcept C2779488553 @default.
• W2043934883 hasConcept C2780687700 @default.
• W2043934883 hasConcept C2780733359 @default.
• W2043934883 hasConcept C2780876324 @default.
• W2043934883 hasConcept C37000724 @default.
• W2043934883 hasConcept C70410870 @default.

• next